LSIPR 50 2018: Frank Kalkbrenner


Frank Kalkbrenner was selected in the LSIPR 50 2018 publication for​ ​his influence on the life sciences industry. He featured in the investment section, as LSIPR reports.

Name: Frank Kalkbrenner

Organisation: Boehringer Ingelheim Venture Fund

Position: Managing Director

LSIPR 50 2018, Frank Kalkbrenner, investment, Boehringer Ingelheim Venture Fund, digital health, portfolio, biotech, cancer, start-ups, immune oncology